Evidence map›Paper›PMID 34185571›Full record

GuidelineJCO global oncology2021

Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline.

Verna D Vanderpuye, Jean Rene V Clemenceau, Sarah Temin, Zeba Aziz, William M Burke, Nixon Leonardo Cevallos, Linus T Chuang, Terence J Colgan, Marcela G Del Carmen, Keiichi Fujiwara and 8 more

Abstract readPractice Guideline
In one paragraph

Guideline in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Guideline
  5. Trial
  6. Article
  7. Ovarian cancer.Nature reviews. Disease primers · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Tackling disease-related malnutrition in resource-limited settings: An international position paper based on expert consensus.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Verna D VanderpuyeKorlebu Teaching Hospital, Accra, Ghana.ORCID 0000-0003-3656-6965
Jean Rene V ClemenceauHospital Angeles Del Pedregal, Mexico City, Mexico.
Sarah TeminAmerican Society of Clinical Oncology, Alexandria, VA.ORCID 0000-0002-1834-0551
Zeba AzizHameed Latif Hospital, Lahore, Pakistan.ORCID 0000-0001-5032-4503
William M BurkeStony Brook University Hospital, Stony Brook, NY.
Nixon Leonardo CevallosSociedad Lucha Contra Cancer Ecuador, Machala, Ecuador.
Linus T ChuangNuvance Health System, Danbury, CT.
Terence J ColganNational Cancer Institute, Bethesda, MD.
Marcela G Del CarmenLifeLabs, Ontario, Canada.
Keiichi FujiwaraMassachusetts General Hospital, Boston, MA.ORCID 0000-0002-7388-0243
Elise C KohnSaitama Medical University International Medical Center, Saitama, Japan.
Jose Enrique Gonzáles NogalesInstituto Nacional de Cancerología, La Paz, Bolivia.
Thomas Okpoti KonneyKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Asima MukhopadhyayChittaranjan National Cancer Institute, Kolkata, India.
Bishnu D PaudelNAMS, Bir Hospital, Kathmandu, Nepal.ORCID 0000-0002-8817-7585
Icó TóthMallow Flower Foundation, Dunaharaszti, Hungary.
Sarikapan WilailakRamathibodi Hospital, Mahidol University, Bangkok, Thailand.
Rahel G GhebreUniversity of Minnesota Medical School, Minneapolis, MN.ORCID 0000-0001-7049-290X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo provide expert guidance to clinicians and policymakers in three resource-constrained settings on diagnosis and staging of adult women with ovarian masses and treatment of patients with epithelial ovarian (including fallopian tube and primary peritoneal) cancer.

methodsA multidisciplinary, multinational ASCO Expert Panel reviewed existing guidelines, conducted a modified ADAPTE process, and conducted a formal consensus process with additional experts.

resultsExisting sets of guidelines from eight guideline developers were found and reviewed for resource-constrained settings; adapted recommendations from nine guidelines form the evidence base, informing two rounds of formal consensus; and all recommendations received ≥ 75% agreement. RECOMMENDATIONS: Evaluation of adult symptomatic women in all settings includes symptom assessment, family history, and ultrasound and cancer antigen 125 serum tumor marker levels where feasible. In limited and enhanced settings, additional imaging may be requested. Diagnosis, staging, and/or treatment involves surgery. Presurgical workup of every suspected ovarian cancer requires a metastatic workup. Only trained clinicians with logistical support should perform surgical staging; treatment requires histologic confirmation; surgical goal is staging disease and performing complete cytoreduction to no gross residual disease. In first-line therapy, platinum-based chemotherapy is recommended; in advanced stages, patients may receive neoadjuvant chemotherapy. After neoadjuvant chemotherapy, all patients should be evaluated for interval debulking surgery. Targeted therapy is not recommended in basic or limited settings. Specialized interventions are resource-dependent, for example, laparoscopy, fertility-sparing surgery, genetic testing, and targeted therapy. Multidisciplinary cancer care and palliative care should be offered.Additional information can be found at www.asco.org/resource-stratified-guidelines. It is ASCO's view that health care providers and health care system decision makers should be guided by the recommendations for the highest stratum of resources available. The guideline is intended to complement but not replace local guidelines.

Indexed as

Ovarian NeoplasmsAdultCA-125 AntigenCarcinoma, Ovarian EpithelialCytoreduction Surgical ProceduresFemaleHumansNeoadjuvant TherapyCA-125 Antigen

Identifiers

PMID34185571
PMCPMC8457806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.